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ABSTRACT
Background: The reactive oxygen and nitrogen species generated during re-
perfusion of tissue are characteristic of intestinal ischemia and reperfusion (IIR) 
injury.
Objective: This study was designed to assess whether the administration of 
aminoguanidine (AG), a selective nitric oxide synthase inhibitor, and/or melatonin 
has protective potential in IIR injury.
Methods: Male Wistar albino rats (age, 3–4 weeks; weight, 100–150 g) were 
divided in a nonrandom fashion into 5 groups of equal size: group 1, IIR injury + AG 
100 mg/kg; group 2, IIR injury + melatonin 10 mg/kg; group 3, IIR injury + AG 
100 mg/kg + melatonin 10 mg/kg; group 4, sham operation; and group 5, IIR injury 
alone. Sixty minutes of intestinal ischemia and 4 hours of reperfusion were carried out 
in all but the sham-operation group. Ileal specimens were obtained from all rats to 
determine the extent of histologic changes, measure tissue concentrations of malondi-
aldehyde (MDA) and protein carbonyl (PC), and assess the activity of superoxide 
dismutase (SOD) and glutathione peroxidase (GPx). Specimens were also assessed and 
scored by a pathologist blinded to the experiment and the data.
Results: Forty rats were divided into 5 groups of 8 each; all 40 survived until study 
end. In the IIR injury-alone group, mean (SD) MDA concentration and PC content were 
significantly higher than that of the sham-operation group, and SOD and GPx activity 
were significantly lower: MDA concentration, 0.86 (0.03) versus 0.54 (0.01) mmol/g 
protein, respectively; PC content, 0.60 (0.02) versus 0.34 (0.01) mmol/g protein; 
SOD activity, 104.33 (43.14) versus 2954.72 (109.55) U/g protein; and GPx activity, 
10.44 (0.63) versus 24.34 (1.77) U/g protein (all, P < 0.001). Administration of AG, 
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melatonin, and the AG/melatonin combination was associated with significantly higher 
SOD (1802.31 [102.35], 1776.50 [58.41], and 1924.28 [98.10] U/g protein, respec-
tively) and GPx (17.36 [1.23], 15.96 [1.08], and 18.06 [1.72] U/g protein) activity and 
significantly lower MDA concentration (0.62 [0.02], 0.64 [0.02], and 0.56 [0.01] mmol/g 
protein) and PC content (0.53 [0.03], 0.51 [0.01], and 0.49 [0.02] mmol/g protein) com-
pared with the IIR injury-alone group (P < 0.001). Mean intestinal mucosal injury 
scores were significantly lower in the 3 treatment groups (2.12 [0.35], 1.75 [0.46], and 
1.12 [0.35]) compared with the IIR injury-alone group (3.87 [0.35]; all, P < 0.001).
Conclusion: In this study, AG, melatonin, or both administered in combina-
tion were associated with improvements in oxidative markers in this rat model of IIR 
injury. (Curr Ther Res Clin Exp. 2009;70:449–459) © 2009 Excerpta Medica Inc.
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INTRODUCTION
Intestinal ischemia and reperfusion (IIR) injury is a serious clinical condition that can 
affect a wide range of patients of all ages, and may result in severe morbidity or 
mortality.1,2 Ischemia produces a reversible or irreversible injury that develops due to 
circulatory insufficiency in the tissue.1 Conditions that can precede IIR include necro-
tizing enterocolitis in newborns, malrotation and volvulus in older infants, bleeding, 
hypovolemia, cardiac insufficiency, trauma, incarcerated inguinal hernia, invagina-
tion, hypoxia, hypotension, and coagulopathy.1–3
IIR can compromise the integrity of the mucosal endothelial and epithelial barrier and 
can derange intestinal motility, provoking local and systemic damage.4,5 Some of the func-
tion lost after ischemia may be regained by reperfusion of the tissue, but reperfusion also 
accelerates the formation of oxygen-derived reactive oxygen species (ROS). Oxygen free 
radical generation is a critical mechanism that causes injury, such as oxidative stress, in 
postischemic cells and tissues.6–8 ROS can damage lipids, proteins, and DNA structures 
because they have an unpaired high-energy electron.7 Production of ROS during ischemia 
or the reperfusion period includes the creation of superoxide, hydrogen peroxide, and hy-
droxyl radicals, which release activated neutrophils.9 Malondialdehyde (MDA) is a second-
ary product of lipid peroxidation and is released as a result of the toxic effect of ROS.10,11 
Protein oxidation can be evaluated by measurement of the protein carbonyl (PC) content.12 
The role of oxidative mechanisms in ischemia suggests that antioxidants may help address 
this clinical problem, and related experimental studies have been conducted.13–16
Aminoguanidine (AG) is a selective inducible nitric oxide synthase (iNOS) inhibi-
tor that has been reported, in previous studies, to have direct antioxidant activity and 
a preventive effect against tissue damage caused by ROS.17–19 Melatonin, an antioxi-
dant and free radical scavenger, has also been reported to have a preventive effect 
against ischemia/reperfusion injury in the heart, kidney, and intestines.20,21
This study investigated the effects of AG and melatonin on levels of the oxidative 
damage markers MDA and PC, on the activity of the antioxidant enzymes superoxide 
dismutase (SOD) and glutathione peroxidase (GPx), and on intestinal histopathologic 
changes in a rat model of IIR injury.
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MATERIALS AND METHODS
This study complied with the current laws and regulations of the Institutional Animal 
Care and Use Committee with the permission of the Ethical Committee of Laboratory 
Animals of Gülhane Military Medical Academy.
Male Wistar albino rats  (age, 3–4 weeks; weight, 100–150 g) were included in the 
study. The animals were kept in separate cages in a controlled room (temperature, 
20°C–25°C; humidity, 70%–80%; 12-hour light/dark cycle). Standardized rat chow 
and tap water was provided ad libitum until 12 hours before the procedure. The rats 
were divided equally in a nonrandom fashion into 5 groups: group 1, IIR injury + 
AG; group 2, IIR injury + melatonin; group 3, IIR injury + AG + melatonin; group 4, 
sham operation; and group 5, IIR injury alone. AG was dissolved in saline and ad-
ministered intraperitoneally at a dose of 100 mg/kg 1 hour before intraperitoneal 
operation; 10 mg/kg melatonin was administered intragastrically at 24 hours and 
1 hour before intraperitoneal operation.22,23 The operations were carried out under 
anesthesia (ketamine 20 mg/kg and xylazine 2 mg/kg) and sterile conditions. The 
superior mesenteric artery was isolated at its origin through a midline laparotomy 
and occluded with an atraumatic microvascular artery clamp for 60 minutes. Ische-
mia was confirmed by the loss of mesenteric pulsations and blanching of the intes-
tine. During the ischemic episode, the abdominal incision was temporarily closed 
to prevent hypothermia. After ischemia, the microvascular clamp was removed and 
reperfusion was confirmed by the restoration of pulsation and color before closing 
the incision. The sham-operation group was subjected to laparotomy without clamp 
application. After 4 hours of reperfusion, tissue samples were obtained from the 
terminal ileum, 10 cm proximal to the ileocecal region. Rats were euthanized by 
cervical dislocation, and intestinal tissues (liver and kidney tissues were sampled 
but the data are not presented) were harvested for biochemical and histopathologic 
analyses. The resected tissues were flushed with 10 mL of cold physiologic saline to 
remove blood and to interrupt the metabolism, and a specimen was fixed in 10% 
buffered formalin for histopathologic analysis. The remaining specimens were 
rinsed with cold saline solution and were stored at –80°C for further biochemical 
examination.
Biochemical Analyses
Frozen tissues were homogenized in phosphate buffer (pH 7.4) on ice. The super-
natant was stored at –70°C. The protein content of tissue homogenates was measured 
using a previously established method24 with bovine serum albumin as the standard.
Tissue PC content concentration was measured by a spectrophotometric method de-
scribed by Levine et al,12 in which carbonyl groups reacted with 2,4-dinitrophenylhydrazine 
to form 2,4-dinitrophenylhydrazone. The PC content concentration is expressed as 
nmol/g protein.
Lipid peroxidation level was measured by the thiobarbituric acid reaction described 
by Ohkawa et al.25 This method was used to obtain a spectrophotometric measure-
ment of the color produced during the reaction to thiobarbituric acid with MDA at 
535 nm. The MDA concentration is expressed as nmol/g protein.
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SOD activity was assayed using the nitroblue tetrazolium method described by Sun 
et al.26 Nitroblue tetrazolium was reduced to blue formazan by superoxide anion 
(O2
–), which has a strong absorbance at 560 nm. One unit (U) of SOD is defined as 
the amount of protein that inhibits the rate of nitroblue tetrazolium reduction by 
50%. The calculated SOD activity is expressed as U/g protein.
GPx activity was measured using the method described by Paglia and Valentine,27 
in which GPx activity was coupled with the oxidation of nicotinamide adenine di-
nucleotide phosphate (NADP) by glutathione reductase. The oxidation of NADP was 
spectrophotometrically followed up at 340 nm at 37°C. The absorbance at 340 nm 
was recorded kinetically for 5 minutes in 15-second intervals. The activity was mea-
sured as the slope of the lines; mmol of NADP oxidized per minute. GPx activity is 
expressed as U/g protein.
Histopathologic Evaluation
Formalin-fixed tissue specimens were embedded in paraffin and cut into 5-mm sec-
tions. Slides were stained with hematoxylin and eosin and examined under a light 
microscope. Intestinal injury was classified using a 5-tiered scale defined by Chiu et al28 
as follows: grade 0 = no diagnostic change; grade 1 = epithelial layer lifting from the 
lamina propria, usually at the apex of the villus; grade 2 = moderate epithelial cell 
layer lifting from the lamina propria; grade 3 = loss of a few villi with massive epi-
thelial lifting from the lamina propria with a few denuded villi; and grade 4 = disin-
tegration of the lamina propria with ulceration and hemorrhage. Each slide was 
evaluated by an experienced pathologist who was blinded to the experiment and the 
data. The slides were randomly numbered and then given to the pathologist for 
scoring.
Statistical Analysis
Statistical analyses were carried out using SPSS for Windows version 11.0 statistical 
software (SPSS Inc., Chicago, Illinois). Results were expressed as mean (SD). Numeric 
data were analyzed using normality plots with tests to determine whether the data 
were in normal distribution, after which a Bonferroni-adjusted ANOVA test was used. 
P values of <0.05 were regarded as statistically significant.
RESULTS
Biochemical data are presented in Table I. The IIR injury-alone group had signifi-
cantly lower SOD and GPx activity compared with the sham-operation group (mean 
[SD], SOD: 104.33 [43.14] vs 2954.72 [109.55], respectively; GPx: 10.44 [0.63] 
vs 24.34 [1.77]; both, P < 0.001). The combination of AG + melatonin was associ-
ated with a significant increase in the intestinal SOD and GPx content compared 
with the melatonin-alone group (mean, SOD: 1924.28 [98.10] vs 1776.50 [58.41], 
respectively [P = 0.013]; GPx: 18.06 [1.72] vs 15.96 [1.08] [P = 0.030]). Mean 
MDA concentration in intestinal tissues was significantly higher in the IIR injury-
alone group than in the sham-operation group (0.86 [0.03] vs 0.54 [0.01], respec-
tively; P < 0.001). The administration of AG or melatonin was associated with lower 
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Table I.  Biochemical evaluation of terminal ileum from rats with intestinal ischemia and reperfusion (IIR) injury (N = 40). Data 
are mean (SD).
   IIR + AG 
 IIR + AG IIR + Melatonin 100 mg/kg + 
 100 mg/kg 10 mg/kg Melatonin 10 mg/kg Sham Operation IIR Injury Alone 
 (n = 8) (n = 8) (n = 8) (n = 8) (n = 8)
MDA, mmol/g protein 0.62 (0.02)*† 0.64 (0.02)*† 0.56 (0.01)† 0.54 (0.01) 0.86 (0.03)*
PC, mmol/g protein 0.53 (0.03)*† 0.51 (0.01)*† 0.49 (0.02)*† 0.34 (0.01) 0.60 (0.02)*
SOD, U/g protein 1802.31 (102.35)*† 1776.50 (58.41)*† 1924.28 (98.10)*†‡ 2954.72 (109.55) 104.33 (43.14)*
GPx, U/g protein 17.36 (1.23)*† 15.96 (1.08)*† 18.06 (1.72)*†§ 24.34 (1.77) 10.44 (0.63)*
AG = aminoguanidine; MDA = malondialdehyde; PC = protein carbonyl; SOD = superoxide dismutase; GPx = glutathione peroxidase.
*P < 0.001 versus sham-operation group.
†P < 0.001 versus IIR injury-alone group.
‡P = 0.013 versus IIR + melatonin group.
§P = 0.030 versus IIR + melatonin group.
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MDA concentration compared with the IIR injury-alone group (AG, 0.62 [0.02] vs 
0.86 [0.03], respectively; melatonin, 0.64 [0.02] vs 0.86 [0.03]; both, P < 0.001), 
with the largest decrease observed in the group receiving the combination of the 
2 agents (0.56 [0.01] vs 0.86 [0.03]; P < 0.001). The combination of AG + melatonin 
was associated with a significant decrease in the intestinal MDA content compared 
with the AG- and melatonin-alone groups (both, P < 0.001). Intestinal PC content 
concentration in the IIR injury-alone group was significantly higher compared with 
the sham-operation group (0.60 [0.02] vs 0.34 [0.01]; P < 0.001), and a similar paral-
lel increase was seen across the treatment groups (P < 0.001). 
Table II shows the histopathologic scores of the study groups. An evident increase 
in mucosal damage was seen in the rats exposed to IIR. Loss and shortening of villi, 
detachment of the lamina from the mucosa, and loss of some glandular structures were 
observed, especially in the exposure area. In the groups treated with AG and/or mela-
tonin, mucosa and lamina propria were better preserved compared with the IIR group 
(P < 0.001). No histopathologic findings other than laminar detachment were seen in 
the group treated with both AG and melatonin (Figure).
DISCUSSION
This study assessed AG, melatonin, and the combination of the 2 as antioxidant agents 
against intestinal oxidative damage arising from IIR injury.17–19,29 PC and MDA con-
centrations, markers of protein and lipid oxidation, increased in the IIR injury-alone 
group due to oxidative intestinal damage. The IIR injury-alone group also showed low-
ering of SOD and GPx enzyme activity in the intestinal tissue. When IIR was treated 
with the antioxidant agents either individually or in combination, SOD and GPx activ-
ity were higher and PC and MDA concentrations were significantly lower. SOD and 
GPx activity was highest in the group receiving the combination of AG and melatonin. 
The combination-therapy group also had the least evidence of histopathologic damage.
Antioxidant enzymes protect tissues against oxidative damage. When the activity 
of these enzymes decreases, tissue becomes prone to oxidative damage. AG is an anti-
Table II.  Histopathologic evaluation of terminal ileum from rats with intestinal ischemia 
and reperfusion (IIR) injury (N = 40). 
   IIR + AG 
  IIR +  100 mg/kg + 
 IIR + AG Melatonin Melatonin Sham IIR Injury 
 100 mg/kg 10 mg/kg 10 mg/kg Operation Alone  
 (n = 8) (n = 8) (n = 8) (n = 8) (n = 8)
Degree of  
mucosal  
damage,  
mean (SD) 2.12 (0.35)*† 1.75 (0.46)*† 1.12 (0.35)*† 0 (0.00) 3.87 (0.35)*
AG = aminoguanidine.
*P < 0.001 versus sham-operation group.
†P < 0.001 versus IIR injury-alone group.
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oxidant that is assumed to express its effect by decreasing formation of peroxynitrite, 
a powerful oxidant. Nitric oxide (NO) is reported to react with O2
– in the course 
of oxidative damage to form peroxynitrites.30–32 When excessive NO is created by 
iNOS, NO reacts with superoxide anions to form peroxynitrites, which indicates that 
the mitochondrion may be the organelle where peroxynitrites are formed.33,34 Per-
oxynitrites deplete antioxidant systems such as glutathione and protein thiol.35–37 In 
the event of antioxidant system insufficiency, tissue damage and lipid peroxidation 
can occur. AG and iNOS inhibition decrease NO formation, and thereby decrease 
peroxynitrite production. Therefore, oxidative damage to proteins and lipids was re-
Figure.  Histopathologic findings in the (A) sham operation, (B) intestinal ischemia and 
reperfusion (IIR) alone, (C) IIR + aminoguanidine (AG), (D) IIR + melatonin, and 
(E) IIR + AG + melatonin groups. Loss and shortening of villi, detachment of the 
lamina from the mucosa, and loss of some glandular structures were observed in 
the IIR group. In the groups treated with AG and/or melatonin, mucosa and lam-
ina propria were better preserved compared with the IIR group. Laminar detach-
ment was observed in the IIR + AG + melatonin group (hematoxylin and eosin; 
magnification ×100).
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duced, and the cellular antioxidant systems were preserved. We also found that AG was 
associated with reduced intestinal injury and decreased MDA levels in the IIR injury-alone 
group. The efficacy of AG against oxidative damage has been the subject of several studies, 
and those results are consistent with this investigation.9,38,39
SOD is the first defense against superoxides, and it reduces peroxynitrite forma-
tion.8 Sufficient SOD activity must be present in the tissue for this damage reduction 
to occur. The preventive action of AG results from its direct antioxidant effect, and it 
is reported to be an effective hydroxyl radical scavenger.40 The molecular oxygen pro-
vided by reperfusion becomes a superoxide anion by means of xanthine oxidase. Mean-
while, hydrogen peroxide and hydroxyl radicals form, which are responsible for tissue 
damage.41 The action of AG against oxidative damage and lipid peroxidation and its 
antioxidant status in several tissue types have been reported in numerous studies.42–44 
All seem to be consistent with the present investigation.
Melatonin is reported to be a powerful free radical scavenger in both in vivo and in 
vitro studies.45,46 Melatonin is also reported to inhibit poly-ADP-ribose synthase 
activation, and prevent organ damage due to shock, inflammation, or ischemia/
reperfusion injury.47 It exercises a tissue-protective effect by increasing the antioxi-
dant enzyme levels via its specific receptors and protects the cell from death.48 In 
addition to its biological effects, melatonin is a powerful free radical scavenger, which 
suggests a preventive role in ischemia/reperfusion injury.41 
In this study, melatonin appears to have had a significant preventive effect on the 
increase of MDA and PC concentration in rats exposed to IIR. Melatonin also signifi-
cantly preserved the activity of SOD and GPx enzymes compared with the IIR group. 
The preserved intestinal histology in the melatonin group might be attributed to both 
its radical scavenger and antioxidant features.
The present study suggests that AG and melatonin may have protective effects on 
IIR that may be associated with their antioxidant and free radical scavenging proper-
ties. Limitations of this study include the nonrandomized assignment of the rats 
to the various study groups and the differences in drug administration routes used. 
In addition, markers of nitrosative stress and tissue NO levels were not evaluated in 
this study. To better understand the effects of AG and melatonin in IIR injury, tissue 
NO level and iNOS activity should be evaluated in future studies.
CONCLUSIONS
In this study, AG, melatonin, or both administered in combination were associated 
with improvements in oxidative markers in this rat model of IIR injury. Additionally, 
intestinal mucosa was best preserved in the group receiving the combination. This 
suggests that better results were obtained by combining the different effects of both 
agents.
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